BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
M.D. Anderson Cancer Center
Stanford University
Fred Hutchinson Cancer Center
Mayo Clinic
City of Hope Medical Center
Emory University
Uppsala University